Skip to main content
Christopher Willey, MD, Radiation Oncology, Birmingham, AL, Birmingham VA Medical Center

ChristopherWilleyMDPhD

Radiation Oncology Birmingham, AL

Central Nervous System Cancer, Head & Neck, Thoracic Cancer

Professor and Associate Vice Chair of Translational Research, Department of Radiation Oncology, University of Alabama at Birmingham School of Medicine

Dr. Willey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Willey's full profile

Already have an account?

Summary

  • Dr. Christopher Willey is a radiation oncologist in Birmingham, AL and is affiliated with multiple hospitals in the area, including Birmingham Veterans Affairs Medical Center, Children's of Alabama, Cooper Green Hospital, and University of Alabama Hospital. He received his medical degree from Medical University of South Carolina College of Medicine and has been in practice 14 years. He specializes in central nervous system cancer, head & neck, and thoracic cancer.

Education & Training

  • Vanderbilt University Medical Center
    Vanderbilt University Medical CenterResidency, Radiation Oncology, 2004 - 2008
  • Spartanburg Regional Healthcare System
    Spartanburg Regional Healthcare SystemInternship, Transitional Year, 2003 - 2004
  • Medical University of South Carolina
    Medical University of South CarolinaClass of 2003

Certifications & Licensure

  • AL State Medical License
    AL State Medical License 2008 - 2024
  • SC State Medical License
    SC State Medical License 2003 - 2004
  • American Board of Radiology Radiation Oncology

Awards, Honors, & Recognition

  • Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • Melanoma Treatment: Potential Target Bypasses Therapeutic Resistance to Immune Checkpoint Blockers
    Melanoma Treatment: Potential Target Bypasses Therapeutic Resistance to Immune Checkpoint BlockersSeptember 16th, 2022
  • Drinking Even a Single Glass of Alcohol Can Trigger a Heart Condition, Study Reveals
    Drinking Even a Single Glass of Alcohol Can Trigger a Heart Condition, Study RevealsSeptember 18th, 2021
  • UAB Researchers Identify Potential Therapeutic Target Against Malignant Brain Tumors
    UAB Researchers Identify Potential Therapeutic Target Against Malignant Brain TumorsApril 5th, 2021
  • Join now to see all

Hospital Affiliations